Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
59:17
59:17
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
59:17
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
47:34
47:34
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
47:34
Dr Jonathan W Goldman from UCLA Health in Santa Monica, California, summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
1:06:09
1:06:09
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:06:09
Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publicat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
1:02:25
1:02:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:25
Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
1:02:36
1:02:36
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:36
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
1:00:49
1:00:49
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:49
Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas, moderated by Dr Neil L…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
1:03:58
1:03:58
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:03:58
Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and se…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
1:00:06
1:00:06
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:06
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer
1:23:41
1:23:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:23:41
Dr Petros Grivas from the Fred Hutchinson Cancer Center in Seattle, Washington, discusses the current management of advanced urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
2:35:49
2:35:49
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:35:49
Dr William J Gradishar from Northwestern Medicine Feinberg School of Medicine in Chicago, Illinois, Dr Virginia Kaklamani from UT Health San Antonio MD Anderson Cancer Center in Texas, Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, and Dr Seth Wander from Massachusetts General Hospital in Boston, discuss key findings and…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
1:00:48
1:00:48
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:48
Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets, moderated by Dr Neil Love. Produced by Research To Practice. CME informat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
1:02:31
1:02:31
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:31
Dr Matthew Galsky from The Tisch Cancer Institute in New York and Dr Ashish Kamat from The University of Texas MD Anderson Cancer Center in Houston summarize recent clinical advances in the management of urothelial bladder cancer, including data from the 2024 AUA annual meeting, moderated by Dr Neil Love. Produced by Research To Practice. CME infor…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Key Presentations on Lymphoma from Recent Major Conferences
1:16:45
1:16:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:16:45
Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bispecific Antibodies in the Management of Multiple Myeloma
42:08
42:08
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
42:08
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
33:54
33:54
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
33:54
Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
1:16:31
1:16:31
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:16:31
Dr Adam M Brufsky from UPMC Hillman Cancer Center in Pittsburgh summarizes the history of and modern advances in treating localized HER2-positive breast cancers, including strategies for monitoring and managing treatment-related toxicities. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
1:02:14
1:02:14
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:14
Drs Naval Daver and Courtney D DiNardo, both from The University of Texas MD Anderson Cancer Center in Houston, summarize the clinical progress in diagnosing and treating acute myeloid leukemia over the past year, as well as practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice. CME info…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
2:13:00
2:13:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:13:00
Drs Rita Nanda, Sara M Tolaney, Julia Foldi, Laura Huppert and Saba Shaikh discuss available and emerging research, patient cases from participating junior clinical investigators and senior clinical investigator perspectives on relevant research data informing clinical decision-making for patients with metastatic triple-negative breast cancer, mode…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
1:07:21
1:07:21
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:07:21
Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
59:39
59:39
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
59:39
Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
1:00:47
1:00:47
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:47
Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
1:37:05
1:37:05
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:37:05
Dr Carlos de Castro, Prof Alexander Röth and Dr Ilene Weitz summarize the biology of paroxysmal nocturnal hemoglobinuria, current treatment approaches, and practical considerations for patients with the disease, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
59:51
59:51
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
59:51
Dr Emmanuel Antonarakis from the University of Minnesota in Minneapolis reviews research findings presented at the 2024 Genitourinary Cancers Symposium and provides his perspectives on current and novel treatment approaches for prostate cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
1:04:28
1:04:28
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:04:28
Dr Naveen Pemmaraju from The University of Texas MD Anderson Cancer Center in Houston discusses updated findings from ASH 2023 on management approaches for myelofibrosis and polycythemia vera, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
37:19
37:19
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
37:19
Dr Kanwal Raghav from The University of Texas MD Anderson Cancer Center in Houston discusses the role of HER2-directed therapy in the treatment of gastrointestinal tumors beyond gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
1:35:00
1:35:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:35:00
Dr Bita Fakhri from Stanford University in Stanford, California, discusses recent updates from ASH 2023 for the management of chronic lymphocytic leukemia and Richter’s syndrome, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
58:42
58:42
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
58:42
Professor Thierry André from the Hôpital Saint-Antoine in Paris, France, and Dr Arvind Dasari from MD Anderson Cancer Center in Houston, Texas, discuss recent developments regarding available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications her…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
1:00:56
1:00:56
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:56
Dr Shilpa Gupta from the Taussig Cancer Institute in Cleveland, Ohio, and Prof Thomas Powles from the Barts Cancer Institute in London, United Kingdom, discuss clinical decision-making with numerous treatment strategies for urothelial bladder cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publication…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
1:14:02
1:14:02
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:14:02
Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
1:01:37
1:01:37
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:01:37
Dr Andrew J Armstrong from the Duke Cancer Institute Center in Durham, North Carolina and Dr Maha Hussain from Robert H Lurie Comprehensive Cancer Center in Chicago summarize recent data sets from 2023 on hormonal therapies and other emerging treatment approaches for patients with prostate cancer, moderated by Dr Neil Love. Produced by Research To …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
1:00:13
1:00:13
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:13
Dr Andrew M Evens from the Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Sonali M Smith from the University of Chicago in Illinois discuss clinical decision-making with numerous treatment strategies for lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
1:19:45
1:19:45
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:19:45
Dr Seth Wander from Harvard Medical School in Boston, Massachusetts, discusses mechanisms underlying endocrine resistance in breast cancer and optimal therapeutic approaches for patients who experience disease progression while or after receiving endocrine therapy, moderated by Dr Neil Love. Produced by Research To Practice. CME information and sel…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
1:01:41
1:01:41
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:01:41
Dr Robin K (Katie) Kelley from the UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, California, and Dr Mark Yarchoan from the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore, Maryland, discuss clinical decision-making with numerous treatment strategies for hepatocellular carcinoma and biliary tract cancers. CME informat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
1:02:49
1:02:49
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:49
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
1:05:37
1:05:37
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:05:37
Dr Ian E Krop from the Yale Cancer Center in New Haven, Connecticut, and Dr Priyanka Sharma from the University of Kansas Cancer Center in Westwood, Kansas, discuss patient cases and treatment strategies for HER2-positive and triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Virtual Case Library: Metastatic Urothelial Bladder Cancer
2:08:14
2:08:14
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
2:08:14
Drs Petros Grivas, Vadim S Koshkin, Kriti Mittal, Mamta Parikh and Scott T Tagawa discuss available and emerging research, patient cases from participating junior clinical investigators and the perspectives of senior clinical investigator faculty on data informing their decision-making for patients with metastatic urothelial bladder cancer, moderat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
37:32
37:32
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
37:32
Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York City discusses available and emerging data with oral SERDs for patients with ER-positive metastatic breast cancer. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
1:00:04
1:00:04
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:04
Dr Stephen T Oh from Washington University School of Medicine in St Louis, Missouri, discusses current and emerging monitoring and management strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
1:02:36
1:02:36
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:02:36
Dr Yelena Y Janjigian from Memorial Sloan Kettering Cancer Center in New York and Dr Zev Wainberg from UCLA Jonsson Comprehensive Cancer Center in Los Angeles discuss the management of gastroesophageal cancers and review emerging data sets in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publicat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
58:01
58:01
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
58:01
Dr Lindsey Roeker from Memorial Sloan Kettering Cancer Center in New York, New York, and Dr Jeff Sharman of the US Oncology Network in Eugene, Oregon, discuss relevant datasets from 2023 on the management of chronic lymphocytic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
1:00:25
1:00:25
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:25
Dr Ahmed Omar Kaseb from the University of Texas MD Anderson Cancer Center in Houston, Texas, and Prof Arndt Vogel from Schwartz Reisman Liver Research Centre in Toronto, Ontario, discuss the optimal selection and sequencing of checkpoint inhibitor therapy for patients with hepatobiliary cancers, moderated by Dr Neil Love. Produced by Research To P…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
59:44
59:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
59:44
Dr Bradley J Monk from the Florida Cancer Specialists & Research Institute in West Palm Beach, Florida, discusses real-world patient cases and treatment strategies for ovarian cancer. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
1:04:44
1:04:44
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:04:44
Dr Stephanie L Graff from the Legorreta Cancer Center at Brown University in Providence, Rhode Island, and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston discuss treatment decision-making involving approved and investigational strategies for the management of hormone receptor-positive breast cancer. CME information and select publicatio…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
1:01:29
1:01:29
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:01:29
Dr Antonio González-Martín from the Clínica Universidad de Navarra in Madrid, Spain, discusses real-world patient cases and treatment strategies for ovarian cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
1:00:18
1:00:18
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:18
Dr Richard M Stone from Dana-Farber Cancer Institute in Boston discusses the optimal selection and sequencing of systemic therapies for patients with acute myeloid leukemia and myelodysplastic syndromes, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
1:05:28
1:05:28
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:05:28
Dr David M O’Malley from The Ohio State University and the James Comprehensive Cancer Center in Columbus, Ohio discusses the role of HER2-directed therapy in the treatment of gynecologic cancers. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
1:00:17
1:00:17
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:00:17
Dr Lipika Goyal from The Stanford Cancer Center and Dr Milind Javle from The University of Texas MD Anderson Cancer Center in Houston discuss targeted and immunotherapeutic approaches for biliary tract cancers, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
1:30:16
1:30:16
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:30:16
Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer, moderated by Neil Love. Prod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
1:01:54
1:01:54
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:01:54
Featuring a discussion on optimizing the management of gastroesophageal cancers with Dr Samuel J Klempner, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.Research To Practice による
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
1:03:00
1:03:00
「あとで再生する」
「あとで再生する」
リスト
気に入り
気に入った
1:03:00
Dr Aditya Bardia from Massachusetts General Hospital and Dr Sara M Tolaney from the Dana-Farber Cancer Institute, both in Boston, Massachusetts, discuss key presentations on the management of breast cancer from the 2023 ESMO Congress, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.…
…
continue reading